Crusoe CEO defends CoreWeave amid selloff

Access to this page has been denied because we believe you are using automation tools to browse the website. This{...}

Merck & Co. (MRK) is close to an approximately $6 billion all-cash deal to buy US biotech firm Terns Pharmaceuticals{...}

Only 7% of traders are anticipating an interest rate hike at the Federal Reserve’s September meeting in the wake of{...}